Doximity (NYSE:DOCS) Surpasses Q4 Revenue Outlook; Stock Plummets 32.5% Post-Earnings

Doximity (NYSE:DOCS) reported Q4 CY2025 results exceeding revenue expectations, with sales up 9.8% year-on-year to $185.1 million. Next quarter guidance for $143.5 million was 5.2% below estimates, sending the stock down 32.5% to $22.50 in after-hours trading. Non-GAAP profit of $0.46 per share beat by 2.9% and EBITDA estimates. Key metrics: CAC payback period 6.4 months; 29.3% CAGR over five years; 16.7% annualized growth over the past two years. With over 80% of U.S. physicians as members, Doximity’s digital platform serves healthcare professionals in collaboration, career management, and virtual visits. Analysts project 9% revenue growth over the next 12 months, down from recent years, amid potential demand headwinds.